Top Markets
#1 MowCat MowCat +48.91%
#2 Velvet Velvet +30.94%
#3 Bermuda Shorts Bermuda Shorts +24.91%
#4 Derive Derive +20.62%
#5 Quack AI Quack AI +19.12%
#6 Audiera Audiera +18.88%
#7 aPriori aPriori +18.67%
#8 Biconomy Biconomy +17.86%
#9 Geodnet Geodnet +11.70%
#10 DUSK Network DUSK Network +9.97%
Coin of the day
MowCat MowCat
설정
언어
한국어
통화
USD
테마
Tricida, Inc. Tricida, Inc.

Tricida, Inc.

TCDA
주식 순위 #35026
Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the... Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the advancement and market introduction of veverimer (TRC101). This compound, an orally ingested, non-systemic polymer, has successfully concluded its Phase III clinical trials. Veverimer is designed to address metabolic acidosis in individuals suffering from chronic kidney disease by specifically targeting and eliminating excess acid within the gastrointestinal tract. The company was established in 2013 and is headquartered in South San Francisco, California.
주가
$0.108
마지막 동기화: 2023-01-23
시가총액
$4.56M
변동 (1일)
-10.00%
변동 (1년)
0.00%
국가
US
거래 Tricida, Inc. (TCDA)

카테고리

Healthcare
Tricida, Inc. (TCDA)의 주가 이력
최고 종가: $0.16 (2023-01-01 기준)

최저 종가: $27.95 (2018-06-01 기준)
Tricida, Inc.의 주가 이력 (2018 ~ 2026)
연간 주가 성과
연도 성과
2023 -15.79%
2022 -97.77%
2021 12.62%
2020 -81.33%
2019 39.94%
2018 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE